Supplements Were Subject of Many Recent NAD Decisions

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Supplements Were Subject of Many Recent NAD Decisions

Darla M. Fera

October 25, 2018 at 08:03 AM EST

An analysis of recent National Advertising Division (NAD) decisions found that almost one-fifth of the decisions released between August 2017 and July 2018, involved dietary supplements. The analysis of NAD cases was performed by August Horvath with Foley Hoag L.L.P. in Boston. NAD monitors national advertising, and “examines advertising claims made for goods and services as... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Supplements Were Subject of Many Recent NAD Decisions

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Supplements Were Subject of Many Recent NAD Decisions

My Research Folders

Related Articles

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT